Manuscripts

Search by keyword, year, or author name.

Showing 1556 manuscripts.

Association of site-specific and participant-specific factors with retention of children in a long-term pediatric HIV cohort study.

Paige L. Williams, Russell B. Van Dyke, Michelle L. Eagle, Dorothy Smith, Carol A. Vincent, Gregory Ciupak, James M. Oleske, George Seage. Association of site-specific and participant-specific factors with retention of children in a long-term pediatric HIV cohort study.. American Journal Of Epidemiology. 2008. 167: 1375-86. PMID: 18413359

Year

2008

Journal

American Journal Of Epidemiology

Pharmacokinetics, safety and efficacy of lopinavir/ritonavir in infants less than 6 months of age: 24 week results.

Ellen Gould Chadwick, Edmund Capparelli, Ram Yogev, Jorge Pinto, Brian Robbins, John H. Rodman, Jie (Ellen) Chen, Paul Palumbo, Leslie Serchuck, Elizabeth (Betsy) Smith, Michael Hughes. Pharmacokinetics, safety and efficacy of lopinavir/ritonavir in infants less than 6 months of age: 24 week results.. AIDS. 2008. 22: 249 - 255. PMID: 18097227

Year

2008

Journal

AIDS

Study

P1030

Chronic administration of nevirapine during pregnancy: impact of pregnancy on pharmacokinetics

J Hitti, PACTG P1022 Study Team, A Stek, C Hu, S K Burchett, B Best, E Smith, J S Read, H Watts, S Nachman, E M Thorpe Jr, S A Spector, E Jimenez, W T Shearer, M Foca, E V Capparelli, M Mirochnick, F Aweeka, PACTG 1026S Study Team. Chronic administration of nevirapine during pregnancy: impact of pregnancy on pharmacokinetics. HIV Medicine. 2008. 9: 214-20. PMID: 18366444

Year

2008

Journal

HIV Medicine

Study

P1022, P1026S

Safety and Immunogenicity of Recombinant Poxvirus HIV-1 Vaccines in Young Adults on Highly Active Antiretroviral Therapy

Thomas C. Greenough, Coleen K. Cunningham, Petronella Muresan, Margaret McManus, Deborah Persaud, Terence Fenton, Piers Barker, Aditya Gaur, Dennis Panicali, John L. Sullivan, Katherine Luzuriaga. Safety and Immunogenicity of Recombinant Poxvirus HIV-1 Vaccines in Young Adults on Highly Active Antiretroviral Therapy. Vaccine. 2008. 26: 6883-93. PMID: 18940219

Year

2008

Journal

Vaccine

Study

P1059

Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy: The ACTG (AIDS clinical trials group) study 5152s

Francesca J. Torriani, Lauren Komarow, Robert A. Parker, Bruno R. Cotter, Judith Silverstein Currier, Michael P. Dube, Carl J. Fichtenbaum, Mariana Gerschenson, Carol K. Mitchell, Robert L. Murphy, Kathleen E. Squires, James H. Stein. Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy: The ACTG (AIDS clinical trials group) study 5152s. Journal of the American College of Cardiology. 2008. 52: 569-76.

Year

2008

Journal

Journal of the American College of Cardiology

Metabolic and immune activation effects of treatment interruption in chronic HIV-1 infection: implications for cardiovascular risk

Pablo Tebas, W. Keith Henry, Roy Matining, Deborah Weng-Cherng, John L. Schmitz, Hernan Valdez, Nasreen Jahed, Laurie S. Myers, William G. Powderly, David Katzenstein. Metabolic and immune activation effects of treatment interruption in chronic HIV-1 infection: implications for cardiovascular risk. Public Library of Science One. 2008. 3: 1-6.

Year

2008

Journal

Public Library of Science One

Class-sparing regimens for initial treatment of HIV-1 infection

John W. Mellors, Sharon A. Riddler, Richard H. Haubrich, Greg DiRienzo, Lynne Peeples, William G. Powderly, Karin L. Klingman, Kevin W. Garren, Tania George, James F. Rooney, Barbara Brizz, Umesh Gangharam Lalloo, Robert L. Murphy, Susan Swindells, Diane V. Havlir. Class-sparing regimens for initial treatment of HIV-1 infection. New England Journal of Medicine. 2008. 358: 2095-106.

Year

2008

Journal

New England Journal of Medicine